Member baru? Bingung? Perlu bantuan? Silakan baca panduan singkat untuk ikut berdiskusi.

Welcome to Forum Sains Indonesia. Please login or sign up.

April 20, 2024, 01:32:50 AM

Login with username, password and session length

Topik Baru

Artikel Sains

Anggota
Stats
  • Total Tulisan: 139,653
  • Total Topik: 10,405
  • Online today: 166
  • Online ever: 1,582
  • (Desember 22, 2022, 06:39:12 AM)
Pengguna Online
Users: 0
Guests: 172
Total: 172

Aku Cinta ForSa

ForSa on FB ForSa on Twitter

FDA Warns of Suicide Risk for Tramadol

Dimulai oleh riandono, Januari 05, 2011, 12:24:46 PM

« sebelumnya - berikutnya »

0 Anggota dan 1 Pengunjung sedang melihat topik ini.

riandono

May 26, 2010 — The US Food and Drug Administration (FDA) announced yesterday that it has added a warning of suicide risk to the labels of tramadol hydrochloride (Ultram) and tramadol hydrochloride/acetaminophen (Ultracet).

The revised labels instruct clinicians not to prescribe tramadol to patients who are suicidal or addiction-prone, and to exercise caution in prescribing the medications to patients who use alcohol excessively, suffer from emotional disturbance or depression, or take tranquilizers or antidepressants.

"Tramadol-related deaths have occurred in patients with previous histories of emotional disturbances or suicidal ideation or attempts as well as histories of misuse of tranquilizers, alcohol, or other [central nervous system–active] drugs," stated letters sent to healthcare professionals by the FDA and PriCara, the maker of the 2 medications and a division of Ortho-McNeil-Janssen Pharmaceuticals.

The letters, 1 for each medication, noted that tramadol, an opioid, can intensify the effects of other opioids as well as alcohol and illicit drugs that depress the central nervous system.

The letters also warned that people with addiction disorders may seek out tramadol and cited the risk of criminal diversion. However, "concerns about abuse, addiction, and diversion should not prevent the proper management of pain," the letters stated.

More information on the FDA announcement is available on the agency's Web site.

To report adverse events related to the 2 pain medications, contact MedWatch by telephone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online at [pranala luar disembunyikan, sila masuk atau daftar.], or by mail to 5600 Fishers Lane, Rockville, Maryland 20852-9787.

copas dr:
[pranala luar disembunyikan, sila masuk atau daftar.]

---------------------------------------------------------------

wah padahal sering liat resep tramadol + antidepresan, durasi lama

syx

Kutip dari: riandono pada Januari 05, 2011, 12:24:46 PM
wah padahal sering liat resep tramadol + antidepresan, durasi lama

berarti jadi kombinasi mematikan... tinggal tunggu beritanya di media massa. si A terjun bebas dari mall X, si B boogie jumping tanpa tali di plaza Y. perlu diteliti apa si A dan si B lagi mengkonsumsi obat? kalo ada obat terkait dalam kasus gitu data bisa diterbitkan di buletin berita MESO tuh.

riandono

kombinasi mematikan, dengan arti yg sebenaarnya "membuat mati" hehe
btw bung syx berlangganan buletin MESO? ada yg online ga ya?

syx

emang tidak langsung mematikan tetapi mendorong pemakainya untuk mencari mati.

sejak ikut pelatihan pharmacovigilance dikirimi buletin itu. yang barusan saya terima sudah saya kirim ke imel google anda. ga tau ada yang onlen pa tidak.

Huriah M Putra

Waaah..
Ini perlu dicatat.
Mana tau mau melakukan pembunuhan tanpa jejak.
hahaha..
[move]OOT OOT OOT..!!![/move]